SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Aclaris Therapeutics, Inc. (ACRS)

ACRS RSS Feed
Add ACRS Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/6/2016 11:44:47 AM - Followers: 1 - Board type: Free - Posts Today: 0

Aclaris Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 United States 484-324-7933 http://www.aclaristx.com Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACRS
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ACRS News: Securities Registration: Employee Benefit Plan (s-8) 03/15/2017 09:30:41 AM
ACRS News: Annual Report (10-k) 03/15/2017 08:34:16 AM
ACRS News: Current Report Filing (8-k) 03/15/2017 07:16:36 AM
ACRS News: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 03/15/2017 07:00:00 AM
ACRS News: Amended Statement of Beneficial Ownership (sc 13d/a) 03/03/2017 04:39:29 PM
PostSubject
#1   ACRS bullish 22.07 stocktrademan 09/06/16 11:44:47 AM
PostSubject